Yueying Peng

Title: Yueying Peng: Innovator in Cancer Treatment

Introduction

Yueying Peng is a notable inventor based in Hebei, China. She has made significant contributions to the field of oncology through her innovative research and development of pharmaceutical preparations. Her work focuses on improving treatment options for patients suffering from non-Hodgkin's lymphoma.

Latest Patents

Yueying Peng holds a patent for the "Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma." This patent discloses a liposomal pharmaceutical preparation of mitoxantrone designed specifically for treating lymphoma. The invention emphasizes the treatment of aggressive non-Hodgkin's lymphoma, particularly targeting diffuse large B-cell lymphoma and peripheral T-cell lymphoma. The mitoxantrone liposomes are utilized as a single anti-tumor therapeutic agent, without the need for combination with other anti-tumor agents. She has 1 patent to her name.

Career Highlights

Yueying Peng is currently employed at Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Her role at the company allows her to engage in cutting-edge research and development, contributing to advancements in cancer treatment.

Collaborations

Yueying has collaborated with notable colleagues, including Chunlei Li and Kun Lou. These partnerships enhance her research efforts and foster innovation in the pharmaceutical field.

Conclusion

Yueying Peng's work in developing targeted treatments for non-Hodgkin's lymphoma showcases her dedication to improving patient outcomes. Her innovative approach and patent contributions mark her as a significant figure in the realm of cancer research.